These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Galectin-9 Mediates HIV Transcription by Inducing TCR-Dependent ERK Signaling. Colomb F; Giron LB; Premeaux TA; Mitchell BI; Niki T; Papasavvas E; Montaner LJ; Ndhlovu LC; Abdel-Mohsen M Front Immunol; 2019; 10():267. PubMed ID: 30842775 [TBL] [Abstract][Full Text] [Related]
4. Examining the Impact of Galectin-9 on Latent HIV Transcription. Adeniji OS; Giron LB; Abdel-Mohsen M Methods Mol Biol; 2022; 2442():463-474. PubMed ID: 35320541 [TBL] [Abstract][Full Text] [Related]
5. In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection. Tsai P; Wu G; Baker CE; Thayer WO; Spagnuolo RA; Sanchez R; Barrett S; Howell B; Margolis D; Hazuda DJ; Archin NM; Garcia JV Retrovirology; 2016 May; 13(1):36. PubMed ID: 27206407 [TBL] [Abstract][Full Text] [Related]
6. Galectin-9 is rapidly released during acute HIV-1 infection and remains sustained at high levels despite viral suppression even in elite controllers. Tandon R; Chew GM; Byron MM; Borrow P; Niki T; Hirashima M; Barbour JD; Norris PJ; Lanteri MC; Martin JN; Deeks SG; Ndhlovu LC AIDS Res Hum Retroviruses; 2014 Jul; 30(7):654-64. PubMed ID: 24786365 [TBL] [Abstract][Full Text] [Related]
7. Elevated cerebrospinal fluid Galectin-9 is associated with central nervous system immune activation and poor cognitive performance in older HIV-infected individuals. Premeaux TA; D'Antoni ML; Abdel-Mohsen M; Pillai SK; Kallianpur KJ; Nakamoto BK; Agsalda-Garcia M; Shiramizu B; Shikuma CM; Gisslén M; Price RW; Valcour V; Ndhlovu LC J Neurovirol; 2019 Apr; 25(2):150-161. PubMed ID: 30478799 [TBL] [Abstract][Full Text] [Related]
8. Early Initiation of Antiretroviral Therapy Can Functionally Control Productive HIV-1 Infection in Humanized-BLT Mice. Li Q; Tso FY; Kang G; Lu W; Li Y; Fan W; Yuan Z; Destache CJ; Wood C J Acquir Immune Defic Syndr; 2015 Aug; 69(5):519-27. PubMed ID: 26167617 [TBL] [Abstract][Full Text] [Related]
9. The anti-caspase 1 inhibitor VX-765 reduces immune activation, CD4 Amand M; Adams P; Schober R; Iserentant G; Servais JY; Moutschen M; Seguin-Devaux C Elife; 2023 Feb; 12():. PubMed ID: 36800238 [TBL] [Abstract][Full Text] [Related]
14. BCL6 Inhibitor-Mediated Downregulation of Phosphorylated SAMHD1 and T Cell Activation Are Associated with Decreased HIV Infection and Reactivation. Cai Y; Abdel-Mohsen M; Tomescu C; Xue F; Wu G; Howell BJ; Ai Y; Sun J; Azzoni L; Le Coz C; Romberg N; Montaner LJ J Virol; 2019 Jan; 93(2):. PubMed ID: 30355686 [TBL] [Abstract][Full Text] [Related]
15. HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study. Henrich TJ; Hatano H; Bacon O; Hogan LE; Rutishauser R; Hill A; Kearney MF; Anderson EM; Buchbinder SP; Cohen SE; Abdel-Mohsen M; Pohlmeyer CW; Fromentin R; Hoh R; Liu AY; McCune JM; Spindler J; Metcalf-Pate K; Hobbs KS; Thanh C; Gibson EA; Kuritzkes DR; Siliciano RF; Price RW; Richman DD; Chomont N; Siliciano JD; Mellors JW; Yukl SA; Blankson JN; Liegler T; Deeks SG PLoS Med; 2017 Nov; 14(11):e1002417. PubMed ID: 29112956 [TBL] [Abstract][Full Text] [Related]
16. Plasma galectin-9 relates to cognitive performance and inflammation among adolescents with vertically acquired HIV. Moar P; Linn K; Premeaux TA; Bowler S; Sardarni UK; Gopalan BP; Shwe EE; San T; Han H; Clements D; Hlaing CS; Kyu EH; Thair C; Mar YY; Nway N; Mannarino J; Bolzenius J; Mar S; Aye AMM; Tandon R; Paul R; Ndhlovu LC AIDS; 2024 Aug; 38(10):1460-1467. PubMed ID: 38608008 [TBL] [Abstract][Full Text] [Related]
17. Establishment of a Novel Humanized Mouse Model To Investigate Flerin NC; Bardhi A; Zheng JH; Korom M; Folkvord J; Kovacs C; Benko E; Truong R; Mota T; Connick E; Jones RB; Lynch RM; Goldstein H J Virol; 2019 Mar; 93(6):. PubMed ID: 30626677 [TBL] [Abstract][Full Text] [Related]
18. Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation. Gandhi RT; McMahon DK; Bosch RJ; Lalama CM; Cyktor JC; Macatangay BJ; Rinaldo CR; Riddler SA; Hogg E; Godfrey C; Collier AC; Eron JJ; Mellors JW; PLoS Pathog; 2017 Apr; 13(4):e1006285. PubMed ID: 28426825 [TBL] [Abstract][Full Text] [Related]
19. Human Galectin-9 Is a Potent Mediator of HIV Transcription and Reactivation. Abdel-Mohsen M; Chavez L; Tandon R; Chew GM; Deng X; Danesh A; Keating S; Lanteri M; Samuels ML; Hoh R; Sacha JB; Norris PJ; Niki T; Shikuma CM; Hirashima M; Deeks SG; Ndhlovu LC; Pillai SK PLoS Pathog; 2016 Jun; 12(6):e1005677. PubMed ID: 27253379 [TBL] [Abstract][Full Text] [Related]
20. Galectin-9 and VISTA Expression Define Terminally Exhausted T Cells in HIV-1 Infection. Shahbaz S; Dunsmore G; Koleva P; Xu L; Houston S; Elahi S J Immunol; 2020 May; 204(9):2474-2491. PubMed ID: 32205423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]